Joseph F. John
Medical University of South Carolina
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph F. John.
Clinical Infectious Diseases | 1997
David M. Shlaes; Dale N. Gerding; Joseph F. John; William A. Craig; Donald L. Bornstein; Robert A. Duncan; Mark R. Eckman; William E. Farrer; William H. Greene; Victor Lorian; Stuart B. Levy; John E. McGowan; Sindy M. Paul; Joel Ruskin; Fred C. Tenover; Chatrchai Watanakunakorn
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
The American Journal of Medicine | 1993
Maury Ellis Mulligan; Katherine Murray-Leisure; Bruce S. Ribner; Harold C. Standiford; Joseph F. John; Joyce Korvick; Carol A. Kauffman; Victor L. Yu
Methicillin-resistant Staphylococcus aureus (MRSA) has become a major nosocomial pathogen in community hospitals, long-term-care facilities, and tertiary care hospitals. The basic mechanism of resistance is alteration in penicillin-binding proteins of the organism. Methods for isolation by culture and typing of the organism are reviewed. MRSA colonization precedes infection. A major reservoir is the anterior nares. MRSA is usually introduced into an institution by a colonized or infected patient or health care worker. The principal mode of transmission is via the transiently colonized hands of hospital personnel. Indications for antibiotic therapy for eradication of colonization and treatment of infection are reviewed. Infection control guidelines and discharge policy are presented in detail for acute-care hospitals, intensive care and burn units, outpatient settings, and long-term-care facilities. Recommendations for handling an outbreak, surveillance, and culturing of patients are presented based on the known epidemiology.
Antimicrobial Agents and Chemotherapy | 2009
Teruyo Ito; Keiichi Hiramatsu; D. Oliviera; H. de Lencastre; Kunyan Zhang; Henrik Westh; Frances G. O'Brien; Philip M. Giffard; David C. Coleman; Fred C. Tenover; Susan Boyle-Vavra; Robert Skov; Mark C. Enright; Barry N. Kreiswirth; Kwan Soo Ko; Hajo Grundmann; Frédéric Laurent; Johanna U. Ericson Sollid; Angela M. Kearns; Richard V. Goering; Joseph F. John; Robert S. Daum; Bo Söderquist
Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novel SCCmec elements.
Infection Control and Hospital Epidemiology | 1997
David M. Shlaes; Dale N. Gerding; Joseph F. John; William A. Craig; Donald L. Bornstein; Robert A. Duncan; Mark R. Eckman; William E. Farrer; William H. Greene; Victor Lorian; Stuart B. Levy; John E. McGowan; Sindy M. Paul; Joel Ruskin; Fred C. Tenover; Chatrchai Watanakunakorn
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
Infection Control and Hospital Epidemiology | 2013
Cassandra D. Salgado; Kent A. Sepkowitz; Joseph F. John; J. Robert Cantey; Hubert H. Attaway; Katherine Freeman; Peter A. Sharpe; Harold T. Michels; Michael G. Schmidt
OBJECTIVE. Healthcare-acquired infections (HAIs) cause substantial patient morbidity and mortality. Items in the environment harbor microorganisms that may contribute to HAIs. Reduction in surface bioburden may be an effective strategy to reduce HAIs. The inherent biocidal properties of copper surfaces offer a theoretical advantage to conventional cleaning, as the effect is continuous rather than episodic. We sought to determine whether placement of copper alloy-surfaced objects in an intensive care unit (ICU) reduced the risk of HAI. DESIGN. Intention-to-treat randomized control trial between July 12, 2010, and June 14, 2011. SETTINg. The ICUs of 3 hospitals. PATIENTS. Patients presenting for admission to the ICU. METHODS. Patients were randomly placed in available rooms with or without copper alloy surfaces, and the rates of incident HAI and/or colonization with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) in each type of room were compared. RESULTS. The rate of HAI and/or MRSA or VRE colonization in ICU rooms with copper alloy surfaces was significantly lower than that in standard ICU rooms (0.071 vs 0.123; P = .020). For HAI only, the rate was reduced from 0.081 to 0.034 (P = .013). CONCLUSIONs. Patients cared for in ICU rooms with copper alloy surfaces had a significantly lower rate of incident HAI and/or colonization with MRSA or VRE than did patients treated in standard rooms. Additional studies are needed to determine the clinical effect of copper alloy surfaces in additional patient populations and settings.
Journal of Clinical Microbiology | 2012
Michael G. Schmidt; Hubert H. Attaway; Peter A. Sharpe; Joseph F. John; Kent A. Sepkowitz; Andrew Morgan; Sarah E. Fairey; Susan Singh; Lisa L. Steed; J. Robert Cantey; Katherine Freeman; Harold T. Michels; Cassandra D. Salgado
ABSTRACT The contribution of environmental surface contamination with pathogenic organisms to the development of health care-associated infections (HAI) has not been well defined. The microbial burden (MB) associated with commonly touched surfaces in intensive care units (ICUs) was determined by sampling six objects in 16 rooms in ICUs in three hospitals over 43 months. At month 23, copper-alloy surfaces, with inherent antimicrobial properties, were installed onto six monitored objects in 8 of 16 rooms, and the effect that this application had on the intrinsic MB present on the six objects was assessed. Census continued in rooms with and without copper for an additional 21 months. In concert with routine infection control practices, the average MB found for the six objects assessed in the clinical environment during the preintervention phase was 28 times higher (6,985 CFU/100 cm2; n = 3,977 objects sampled) than levels proposed as benign immediately after terminal cleaning (<250 CFU/100 cm2). During the intervention phase, the MB was found to be significantly lower for both the control and copper-surfaced objects. Copper was found to cause a significant (83%) reduction in the average MB found on the objects (465 CFU/100 cm2; n = 2714 objects) compared to the controls (2,674 CFU/100 cm2; n = 2,831 objects [P < 0.0001]). The introduction of copper surfaces to objects formerly covered with plastic, wood, stainless steel, and other materials found in the patient care environment significantly reduced the overall MB on a continuous basis, thereby providing a potentially safer environment for hospital patients, health care workers (HCWs), and visitors.
Antimicrobial Agents and Chemotherapy | 2012
Teruyo Ito; Keiichi Hiramatsu; Alexander Tomasz; Hermínia de Lencastre; Vincent Perreten; Matthew T. G. Holden; David C. Coleman; Richard V. Goering; Philip M. Giffard; Robert Skov; Kunyan Zhang; Henrik Westh; Frances G. O'Brien; Fred C. Tenover; Duarte C. Oliveira; Susan Boyle-Vavra; Frédéric Laurent; Angela M. Kearns; Barry N. Kreiswirth; Kwan Soo Ko; Hajo Grundmann; Johanna U. Ericson Sollid; Joseph F. John; Robert S. Daum; Bo Söderquist; Girbe Buist
Methicillin-resistant staphylococci are disseminated all over the world and are frequent causes of health care- and community-associated infections. Methicillin-resistant strains typically carry the acquired mecA gene that encodes a low-affinity penicillin-binding protein (PBP), designated PBP2a or
Journal of Microbiological Methods | 1995
Yuehuei H. An; Richard J. Friedman; Robert A. Draughn; Edwin A. Smith; James H. Nicholson; Joseph F. John
Abstract A method for rapid enumeration of S. epidermidis adhered to the surface of commercially pure titanium samples was developed using image analyzed epifluorescence microscopy. The method was used to determine the effects of different surface roughnesses of titanium samples and the influence of adsorbed human serum proteins on bacterial adherence. Bacterial suspension of S. epidermidis (VAS-11, concentration: 10 7 cfu/ml) were incubated with titanium samples (with different surface roughnesses and coated with human serum albumin or fibronectin) for 1 h at 37°C with agitation. Thereafter they were washed, stained with propidium iodide, air dried, mounted onto microslides, and counted by using image analyzed epifluorescence microscopy. The results showed that: (1) this direct counting method is quick, simple, accurate, reproducible, and suitable for counting bacteria adhered to opaque surfaces such as netal, (2) the different roughnesses of the titanium surfaces (roughness: 1.25 to 0.44 Ra) had no effect on the S. epidermidis adherence, and (3) adsorbed human serum albumin reduced the S. epidermidis adherence by more than 90%, suggesting that precoating biomaterials with albumin may reduce the possibility of prosthesis or implant colonization by staphylococci. Conversely, human serum fibronection had no effect on S. epidermidis adherence to a titanium surface.
Infection Control and Hospital Epidemiology | 2000
Joseph F. John; Louis B. Rice
Cycling of currently available antibiotics to reduce resistance is an attractive concept. For cycling strategies to be successful, their implementation must have a demonstrable impact on the prevalence of resistance determinants already dispersed throughout the hospital and associated healthcare facilities. While antibiotic use in hospitals clearly constitutes a stimulus for the emergence of resistance, it is by no means the only important factor. The incorporation of resistance determinants into potentially stable genetic structures, including bacteriophages, plasmids, transposons, and the more newly discovered movable elements termed integrons and gene cassettes, forces some degree of skepticism about the potential for such strategies in institutions where resistance determinants are already prevalent. In particular, the expanding role of integrons may pose an ultimate threat to formulary manipulations such as cycling. Despite these concerns, the crisis posed by antimicrobial resistance warrants investigation of any strategy with the potential for reducing the prevalence of resistance. Over the next decade, new studies with carefully designed outcomes should determine the utility of antibiotic cycling as one control measure for nosocomial resistance.
The Journal of Pediatrics | 1983
Joseph F. John; Kelly T. McKee; James A. Twitty; William Schaffner
Multiresistant Klebsiella pneumoniae has been endemic among adult patients at Vanderbilt University Medical Center since 1973. Multiresistant K. pneumoniae was absent from pediatric wards until 1979, when it produced an epidemic in the intensive care nursery followed a year later by a second epidemic involving K. pneumoniae of the same serotype. The 105 megadalton (Md) conjugative resistance (R) plasmid (pCER7999) transferring multiple antibiotic resistance in the adult, endemic strain was found also in isolates from the first epidemic in the intensive care nursery. The mother of a child in the nursery harbored E. coli containing the same 105 Md R plasmid. The second epidemic also involved a 105 Md conjugative R plasmid, which, however, by molecular analysis was different from the first epidemic plasmid and also pCER7999. Thus, the second epidemic resulted from the introduction of a new, unrelated multiresistant K. pneumoniae strain. Contemporary hospital epidemiology often requires the application of molecular techniques for an understanding of nosocomial infections.